Literature DB >> 17223961

Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity.

A G Bowie1.   

Abstract

(TLRs) respond to pathogens to initiate the innate immune response and direct adaptive immunity, and evidence to date suggests that they have a role in the detection of viruses. Many viral macromolecules have been shown to activate anti-viral signalling pathways via TLRs, leading to the induction of cytokines and interferons, while viruses also have means of not only evading detection by TLRs, but also of subverting these receptors for their own purposes. This review discusses the role of TLRs in the context of other known viral detection systems, and examines some of the often surprising results from studies using mice deficient in TLRs and their adaptors, in an attempt to unravel the particular contribution of TLRs to anti-viral immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223961      PMCID: PMC1810468          DOI: 10.1111/j.1365-2249.2006.03301.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  82 in total

1.  Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Kanae Matsumoto; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Eileen Foy; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Shin Yonehara; Atsushi Kato; Takashi Fujita
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

3.  Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner.

Authors:  Jesper Melchjorsen; Søren B Jensen; Lene Malmgaard; Simon B Rasmussen; Friedemann Weber; Andrew G Bowie; Sampsa Matikainen; Søren R Paludan
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10.

Authors:  Geraldine Maloney; Martina Schröder; Andrew G Bowie
Journal:  J Biol Chem       Date:  2005-07-05       Impact factor: 5.157

5.  Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2.

Authors:  Jennifer P Wang; Evelyn A Kurt-Jones; Ok S Shin; Michael D Manchak; Myron J Levin; Robert W Finberg
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

Authors:  Etienne Meylan; Joseph Curran; Kay Hofmann; Darius Moradpour; Marco Binder; Ralf Bartenschlager; Jürg Tschopp
Journal:  Nature       Date:  2005-09-21       Impact factor: 49.962

7.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.

Authors:  Taro Kawai; Ken Takahashi; Shintaro Sato; Cevayir Coban; Himanshu Kumar; Hiroki Kato; Ken J Ishii; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2005-08-28       Impact factor: 25.606

8.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

9.  Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions.

Authors:  Anne-Sophie Beignon; Kelli McKenna; Mojca Skoberne; Olivier Manches; Ida DaSilva; Daniel G Kavanagh; Marie Larsson; Robert J Gorelick; Jeffrey D Lifson; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

10.  Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.

Authors:  Xiao-Dong Li; Lijun Sun; Rashu B Seth; Gabriel Pineda; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

View more
  21 in total

Review 1.  Toll-like receptors regulation of viral infection and disease.

Authors:  Joseph M Thompson; Akiko Iwasaki
Journal:  Adv Drug Deliv Rev       Date:  2007-12-28       Impact factor: 15.470

2.  Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results.

Authors:  Neelam Dhiman; Inna G Ovsyannikova; Robert A Vierkant; Jenna E Ryan; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

3.  Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP.

Authors:  Girish K Radhakrishnan; Qiqi Yu; Jerome S Harms; Gary A Splitter
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

4.  Different expressions of TLRs and related factors in peripheral blood of preterm infants.

Authors:  Jinping Zhang; Jianguo Zhou; Baogan Xu; Chao Chen; Wenjing Shi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 5.  Pattern-recognition receptors in human eosinophils.

Authors:  Anne Månsson Kvarnhammar; Lars Olaf Cardell
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

6.  The interferon-alpha and interleukin-10 responses in neonates differ from adults, and their production remains partial throughout the first 18 months of life.

Authors:  O Vosters; C Lombard; F André; G Sana; E M Sokal; F Smets
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

7.  New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune response.

Authors:  Dilip Ratnam; Kumar Visvanathan
Journal:  Hepatol Int       Date:  2008-02-27       Impact factor: 6.047

Review 8.  Severe sepsis and Toll-like receptors.

Authors:  Hongmei Gao; Susannah K Leaver; Anne Burke-Gaffney; Simon J Finney
Journal:  Semin Immunopathol       Date:  2007-12-11       Impact factor: 9.623

9.  Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation.

Authors:  Martina Schröder; Marcin Baran; Andrew G Bowie
Journal:  EMBO J       Date:  2008-07-17       Impact factor: 11.598

10.  Toll-like receptor 3 has a protective role against West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.